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MotorObstructive sleep apnea (OSA) is accompanied by cognitive, motor, autonomic, learning, and affective abnormali-
ties. The putamen serves several of these functions, especially motor and autonomic behaviors, but whether global
and speciﬁc sub-regions of that structure are damaged is unclear. We assessed global and regional putamen vol-
umes in 43 recently-diagnosed, treatment-naïve OSA (age, 46.4 ± 8.8 years; 31 male) and 61 control subjects
(47.6 ± 8.8 years; 39 male) using high-resolution T1-weighted images collected with a 3.0-Tesla MRI scanner.
Global putamen volumes were calculated, and group differences evaluated with independent samples t-tests, as
well as with analysis of covariance (covariates; age, gender, and total intracranial volume). Regional differences
between groups were visualized with 3D surface morphometry-based group ratio maps. OSA subjects showed
signiﬁcantly higher global putamen volumes, relative to controls. Regional analyses showed putamen areas with
increased and decreased tissue volumes in OSA relative to control subjects, including increases in caudal, mid-
dorsal, mid-ventral portions, and ventral regions, while areas with decreased volumes appeared in rostral, mid-
dorsal,medial-caudal, andmid-ventral sites. Global putamenvolumeswere signiﬁcantly higher in theOSA subjects,
but local sites showedboth higher and lower volumes. The appearance of localized volume alterations points to dif-
ferential hypoxic or perfusion action on glia and other tissues within the structure, and may reﬂect a stage in pro-
gression of injury in these newly-diagnosed patients toward the overall volume loss found in patients with chronic
OSA. The regional changes may underlie some of the speciﬁc deﬁcits in motor, autonomic, and neuropsychologic
functions in OSA.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).ee dimensional; MRI, Magnetic
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Obstructive sleep apnea (OSA) patients show multiple neurobehav-
ioral difﬁculties, including deﬁcits in attention, psychomotor and execu-
tive functioning, memory, and affect (Beebe et al., 2003). However, the
principal deﬁcits in the syndrome involve the loss of motor control
over the upper airway muscles, which fail to discharge in a timely fash-
ion, when they should dilate the airway during diaphragmatic descent,
and a loss of control over autonomic motor activity, with chronic, exag-
gerated sympathetic discharge (Somers et al., 1995), and inappropriate
lagged or muted dynamic sympathetic responses to blood pressure or
ventilatory challenges (Harper et al., 2003; Henderson et al., 2004;
Macey et al., 2006). Those somatic and autonomic motor defects suggest
central injury in motor and autonomic regulatory structures, and gross
damage has been found in multiple sites, based on manual and voxel-
based morphometry of high-resolution T1-weighted images (Kumarthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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2012; Macey et al., 2008), and T2-relaxometry procedures (Cross et al.,
2008; Kumar et al., 2009b). Several of the affected brain sites include
structures that serve both somato motor and autonomic motor roles;
one such structure is the putamen,which showsoverall injury,metabolic
abnormalities, and functional deﬁcits (Alkan et al., 2013; Emin
Akkoyunlu et al., 2013; Kumar et al., 2012; Macey et al., 2006).
The evidence for putamen roles in autonomic regulation is well-
known, especially from pathological conditions with dysautonomia,
such as Multiple Systems Atrophy (Pastakia et al., 1986). Such a role is
expected, considering themajor projections received from the autonom-
ic regulatory insular cortices (Saper, 1982). The putamen somatic motor
role appears to incorporate sensory and other signals to initiate effective
motor action, with putamen stroke inducing conditions of “motor ne-
glect” (Sapir et al., 2007). OSA represents a prime example of how signals
fail to initiate and maintain upper airway muscle discharge, and the
putamen may be playing a signiﬁcant role in that upper airway muscle
“neglect,” particularly considering its projections to brain areas regulat-
ing oral motor functions (Kunzle, 1978; Miyata and Sasaki, 1984).
Theputamenalso contributes to regulationof other neuropsychologic,
cognitive, and learning functions which are deﬁcient in OSA. These func-
tions includememory,mood, language, andmotivation, showdifferential
topographic organization (Alexander and Crutcher, 1990; Badgaiyan
et al., 2008; Booth et al., 2007; Bowman et al., 1996; Husain et al., 1991;
Saper, 1982), and the sub-regions within that organization receive infor-
mation fromprefrontal, insular, and thalamic areas, and send dopaminer-
gic projections to the ventral tegmentum, substantia nigra, and globus
pallidus (Avendano et al., 2006; DeVito et al., 1980; Ferry et al., 2000;
Gorbachevskaya, 1997; Saper, 1982; Schultz and Romo, 1987). Putamen
volumes are reduced in depressed patients (Husain et al., 1991), and
over half of OSApatients are depressed (Asghari et al., 2012); themajority
of OSA subjects also show learning deﬁcits (Wallace and Bucks, 2013).
Regional structural changeswithin the putamen can thus alter infor-
mation transfer between various brain sites. Manual volumetric proce-
dures, using high-resolution T1-weighted images, can evaluate global
putamen volume (Kumar et al., 2011), and 3D surface morphometry
techniques can assess regional tissue changes, as well as extent of
changes within the structures (Butters et al., 2009; Sabattoli et al.,
2008; Shi et al., 2013; Thompson et al., 2004). Both procedures have
been used to examine global and regional basal ganglia structures
(Kumar et al., 2009a), including the putamen (Kumar et al., 2011). The
extent of tissue changes within putamen sub-regions which serve spe-
cialized functions, or project to other brain areas serving unique roles,
is unclear in OSA. Knowledge of localized changes is essential to disclose
functional outcomes, since the functional topography of the putamen is
not uniform.
Our aim was to examine global and regional putamen volumes in
OSA relative to control subjects using high-resolution T1-weighted im-
ages withmanual volumetric and 3D surface morphometry procedures,
and to determine the nature of any volume changes. We selected
newly-diagnosed, untreated OSA patients to avoid confounding mea-
sures with treatment interventions, and to determine tissue changes
as early as possible in the syndrome development. Since OSA subjects
show overall putamen damage, altered metabolites, and functional def-
icits (Alkan et al., 2013; Emin Akkoyunlu et al., 2013; Kumar et al., 2012;
Macey et al., 2006) and severe autonomic, behavioral andmotor deﬁcits
appear in the condition, we hypothesized that both left and right global
and regional putamen integrity would be altered in OSA, compared to
control subjects.
2. Materials and methods
2.1. Subjects
We studied 43 recently-diagnosed (based on overnight
polysomnography; apnea–hypopnea-index ≥ 5) OSA subjectsbefore any treatment, and 61 healthy control subjects. Both OSA
and control subjects included here were subjects in previously-
published manuscripts related to other issues in OSA (Cross et al.,
2008; Kumar et al., 2008, 2009b, 2012; Macey et al., 2008, 2010, 2012,
2013). All OSA subjectswere recruited from the Sleep Disorders Labora-
tory at UCLA, and control subjects were recruited from the UCLA cam-
pus and West Los Angeles area. OSA subjects were not taking any
medications (β-blockers, α-agonists, angiotension-converting enzyme
inhibitors, vasodilators, or serotonin reuptake inhibitors), and were
without any diagnosed history of stroke, heart failure, or mental illness
that might inﬂuence brain tissue composition. Control subjects were in
good health, without any brain disorder which may induce brain tissue
changes. We interviewed the control subjects, as well as their sleep
partners, when available, to determine the potential for sleep disor-
dered breathing, and subjects suspected of having such disturbed pat-
terns underwent an overnight sleep study. OSA and control subjects
with body weight more than 125 kg (scanner limitation), or with MRI
incompatible metallic implants were excluded, as described at the
MRI safety website (http://www.mrisafety.com/). All OSA and control
subjects gave written and informed consent prior to the study, and
the study protocol was approved by the Institutional Review Board at
the University of California at Los Angeles.
2.2. Overnight polysomnography (PSG)
Overnight sleep studies were performed on all OSA subjects at the
UCLA Sleep Disorders Center and Laboratory, and consisted of a
7–10 hour period (9:00 PM to 6:00 AM) monitoring of electroencepha-
logram (EEG— central and occipital), digastric electromyogram (EMG),
electrocardiogram (EKG— lead II), right and left extra-ocular eyemove-
ment (EOG), thoracic and abdominal wall movement, air ﬂow, O2 satu-
ration, end-tidal CO2 levels, snore volume, bilateral leg movement, and
sleep position. Acquired data were digitized, and stored on a computer
for sleep evaluation.
2.3. Examination of daytime sleepiness and sleep quality
We used the Epworth Sleepiness Scale (ESS) and the Pittsburgh
Sleep Quality Index (PSQI) questionnaires to examine daytime sleepi-
ness and sleep quality, respectively, in both OSA and control subjects
(Johns, 1991; Knutson et al., 2006). These commonly-used measures
were self-administered, either before or after MRI data acquisition.
2.4. Assessment of depression and anxiety symptoms
We administered the Beck Depression Inventory (BDI)-II to examine
depressive symptoms, and the Beck Anxiety Inventory to assess anxiety
symptoms inOSA and control subjects (Beck et al., 1988, 1996), either be-
fore or after MRI data collection. Both inventories are self-administered
questionnaires, with scores between 0 and 63, based on the severity of
symptoms (Beck et al., 1988, 1996).
2.5. Magnetic resonance imaging
Brain studies were performed using a 3.0-Tesla MRI scanner
(Magnetom Tim-Trio; Siemens, Erlangen, Germany), with a receive-only
8-channel phased-array head-coil, and a whole-body transmitter coil.
Foampadswere used on both sides of the head to reduce headmotion re-
lated artifacts, and subjects lay supine during data collection.We collected
two high-resolution T1-weighted image scans using a magnetization
prepared rapid acquisition gradient-echo (MPRAGE) pulse sequence
[repetition time (TR) = 2200 ms; echo time (TE) = 2.2 ms; inversion
time = 900 ms; ﬂip angle (FA) = 9°; matrix size = 256 × 256; ﬁeld of
view (FOV) = 230 × 230 mm; slice thickness = 1.0 mm; slices = 176].
Proton density (PD) and T2-weighted images were collected using
a dual-echo turbo spin-echo pulse sequence (TR = 10,000 ms; TE1,
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230 × 230 mm; slice thickness = 4.0 mm; slices = 55; turbo factor =
5). Diffusion tensor imaging data were acquired using a single-shot
echo-planar imaging with twice-refocused spin-echo pulse sequence
(TR = 10,000 ms; TE = 87 ms; ﬂip angle = 90°; band-width =
1346 Hz/pixel; matrix size = 128 × 128; FOV = 230 × 230 mm; slice
thickness = 2.0 mm, b = 0 and 700 s/mm2, diffusion directions = 12).
Four separate DTI series were collected with the same imaging protocol
for subsequent averaging. We used a parallel imaging technique, “gener-
alized autocalibrating partially parallel acquisition (GRAPPA)”, with an
acceleration factor of two for all scans.
2.6. Data processing and analysis
2.6.1. Overnight PSG data
All sleep recordings were interpreted by the UCLA sleep physi-
cians. Sleep states, sleep disordered breathing, and physiology
were assessed ﬁrst for total sleep time, and number and type (cen-
tral, obstructive, or mixed — based on air ﬂow and thoracic and ab-
dominal strain gauges) of apneic episodes. Sleep records were
scored by a registered PSG technician, and then each PSG was
reviewed by the sleep physician. Using the digitized PSG signals,
each one-min data epoch were scored as awake (W), rapid-eye
movement sleep (R), or sleep stages N1–N3, based on recently-
revised scoring criteria (Iber et al., 2007). The apnea–hypopnea-
index (AHI), is a severity index of sleep disordered breathing, com-
bining both apneas and hypopneas, and is calculated by dividing
the number of apnea and hypopnea by the total sleep time. Subjects
were classiﬁed as having OSA based on an AHI≥ 5/h (1999). OSAwas
classiﬁed as “moderate” if AHI N 15, and “severe” if AHI N 30 (1999).
The total number and duration of apnea, AHI, number of arousals, O2
saturation variables, total sleep time, time in each state, and sleep ef-
ﬁciency variables were calculated.
2.6.2. MRI data
High-resolution T1-weighted, PD-, and T2-weighted scans were
visually-examined to assess any major brain lesions (e.g., cystic lesions,
major infarcts, or space occupying lesions). Both high-resolution T1-
weighted scans were also examined for any imaging artifacts before
data processing.
We used the statistical parametric mapping package SPM8
(http://www.ﬁl.ion.ucl.ac.uk/spm/), MRIcroN, and MATLAB-based
(TheMathWorks Inc., Natick, MA) custom software for data processing,
manually-outlining putamen structures, and determination of putamen
volumes.
2.6.2.1. Realignment, averaging, and rigid-body transformation. We
realigned both high-resolution T1-weighted scans to remove any poten-
tial variations between the two series, and averaged the images using
SPM8 software. Averaged images of individual subjects, using uniﬁed
segmentation, were bias-corrected for regional signal intensity differ-
ences, and image volumes were reoriented into Montreal Neurological
Institute (MNI) common space with an afﬁne transformation (Kumar
et al., 2011). The afﬁne-transformed images were resampled to a voxel
size of 0.9 × 0.9 × 0.9 mm, and used to outline manually putamen struc-
tures (Kumar et al., 2011).
2.6.2.2. Gray matter, white matter, and cerebrospinal ﬂuid and intracranial
volume calculation. The averaged and reoriented images of individual
subjects were partitioned into gray, white, and cerebrospinal ﬂuid
(CSF) probability maps using the uniﬁed segmentation method. Within
the gray, white, and CSF probability maps, all voxels with a probability
valueN0.5were counted, andwhole-brain gray, white, and CSF volumes
were calculated.Whole-brain gray, white, and CSF volumeswere added
to determine total intracranial volume (TIV).2.6.2.3. Putamen tracing and global volume quantiﬁcation. We used the
reoriented and resampled brain scans to manually-outline both left
and right putamen structures with MRIcroN software. One investigator,
who was blinded for subject group assignments, outlined putamen
structures in all OSA and control subjects, based on a protocol described
earlier (Kumar et al., 2011). Using these tracings, left and right global
putamen volumes were calculated (Kumar et al., 2011).
2.6.2.4. Calculation of putamen mean diffusivity (MD) values. DTI data
were processed as described previously (Kumar et al., 2012). Brieﬂy,
using diffusion weighted and non-diffusion weighted images, diffusion
tensor matrices were calculated, matrices diagonalized, and principal
eigenvalues were calculated. The principal eigenvalues were used to
calculate MD maps, as described earlier (Kumar et al., 2012).
MDmaps, derived from each DTI series, were realigned, averaged to
create one MD map per subject, and averaged MD maps were normal-
ized to a common space. Similarly, non-diffusion imageswere realigned,
averaged, and normalized to a common space. All normalized non-
diffusion images were averaged to determine a background image,
which was used to create left and right putamen regions-of-interest
masks, guided by the previous ﬁndings (Kumar et al., 2012). Using the
normalized MD maps and left and right putamen region-of-interest
masks, average left and right MD values were derived.
2.6.2.5. Intra-tracer reliability. We examined intra-tracer reliability for
outlining putamen structures by re-outlining those structures in 10
randomly-selected OSA and 10 control subjects by the same investigator
who outlined structures in all OSA and control subjects. Total putamen
volumes were used for intra-tracer reliability calculations. Intra-tracer
reliability was high for putamen tracings (intra-class correlation = 0.91,
p b 0.001), indicating consistent tracings across all subjects.
2.6.2.6. 3D Surface morphometry. We used 3D surface morphometry to
visualize regional putamen volume variations betweenOSA and control
subjects (Butters et al., 2009; Sabattoli et al., 2008; Shi et al., 2013;
Thompson et al., 2004). Both left and right surface models were created
from individual putamen tracings, and 3D meshes were generated in
which each mesh consisted of a ﬁxed number of equally-spaced points.
A medial curve representing center of mass was determined in the
anterior–posterior direction within each mesh, and using the medial
curve, the thickness of the putamen (radial distance) was calculated at
each surface point (Thompson et al., 2004). To visualize the local vol-
ume of putamen sub-regions in the OSA, relative to the control group,
the ratio of mean radial distances at each surface point (OSA/control)
was calculated, color-coded (orange to red, volume losses; blue to purple,
volume increases), and overlaid onto averaged 3D putamen surface
models, determined by averaging all OSA and control surface models.
2.7. Statistical analysis
Data were evaluated using the IBM Statistical Package for the Social
Sciences (IBM SPSS, V 20). We examined numerical demographic, bio-
physical, sleep, and neuropsychologic data (age, body mass index, ESS,
PSQI, BDI-II, and BAI) with independent samples t-tests, and categorical
demographic data (gender) with Chi-square tests. Global putamen
volumes, putamen MD values, gray matter, white matter, CSF, and TIV
values were examined between groups using independent samples
t-tests. Global putamen volumes and putamenMD values were also ex-
amined with analysis of covariance, with age, gender, and TIV included
as covariates for putamen volumes, and age and gender as covariates for
MD values. Pearson's correlation procedures were used to examine the
association between global putamen volumes and BMI, sleep variables,
neuropsychologic scores, putamen MD values, and O2 saturation vari-
ables in OSA subjects. We used linear regression analysis to determine
the impact of clinical, biophysical, and O2 saturation values on global
putamen volumes of OSA subjects. The dependent variables were left
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ESS, PSQI, BDI-II, BAI, and O2 saturation nadir values. We established
intra-tracer reliability with an intra-class correlation procedure.3. Results
3.1. Demographics
Demographic data are summarized in Table 1. Neither age nor
gender differed signiﬁcantly between OSA and control subjects (age,
p = 0.56; gender, p = 0.38). Body mass indices were signiﬁcantly
higher in OSA compared to control subjects (p b 0.001).3.2. Sleep, O2 saturation, and neuropsychologic variables
Sleep, O2 saturation, and neuropsychologic variables of OSA and
control subjects are summarized in Table 1. Both ESS and PSQI scores sig-
niﬁcantly differed between OSA and control subjects (ESS, p b 0.001;
PSQI, p b 0.001). BDI-II and BAI values were signiﬁcantly higher in OSA,
compared to control subjects (BDI-II, p b 0.001; BAI, p = 0.001).Table 1
Characteristics of OSA and control subjects.
Variable type Variables OSA
(Mea
[A]
Demographic Age (years) 46.4
(n =
Gender (Male:Female) 31:12
Biophysical BMI (kg/m2) 30.1
(n =
Sleep AHI (events/h) 31.4
(n =
ESS 10.3
(n =
PSQI 9.3 ±
(n =
O2 saturation Baseline SaO2 (%) 96.3
(n =
SaO2 nadir (%) 77.9
(n =
SaO2 nadir change (%) 18.3
(n =
Obstructive length of nadir (s) 40.6
(n =
Neuropsychological BDI-II 9.3 ±
(n =
BAI 10.7
(n =
Brain (volume) Gray matter (mm3) 700,4
(n =
White matter (mm3) 445,3
(n =
CSF (mm3) 315,2
(n =
TIV (mm3) 1,461
(n =
Putamen (volume) Left putamen (mm3) 4146
4117
(n =
Right putamen (mm3) 4152
4125
(n =
Putamen (MD values) Left putamen (×10−6 mm2/s) 803.1
802.5
n =
Right putamen (×10−6 mm2/s) 784.7
784.2
n =
SD, standard deviation; BMI, body mass index; AHI, apnea–hypopnea-index; ESS, Epworth
Depression Inventory II; BAI, Beck Anxiety Inventory; CSF, cerebrospinal ﬂuid; TIV, total intra
TIV; ##, p value controlled for age and gender.3.3. Global gray, white, and CSF volumes and TIV
Global gray matter, white matter, CSF volumes, and TIV values of
OSA and control group are summarized in Table 1. Gray matter, white
matter, and CSF volumes, aswell as TIV values, did not differ signiﬁcant-
ly between OSA and control subjects (gray matter, p = 0.40; white
matter, p = 0.27; CSF, p = 0.62; TIV, p = 0.82).3.4. Global putamen volumes and MD value differences
Both left and right global putamen volumes of OSA and control sub-
jects are summarized in Table 1, and scatter plots are shown in Fig. 1.
The left and right global putamen volumes were signiﬁcantly higher in
OSA, compared to control subjects (independent samples t-tests;
left, p = 0.041; right, p = 0.025); values were signiﬁcantly higher in
OSA, even after controlling for age, gender, and TIV (ANCOVA; left,
p = 0.043; right, p = 0.027).
Average putamen MD values of OSA and control subjects are
summarized in Table 1. Both left and right putamenMDvalueswere sig-
niﬁcantly lower in OSA, compared to control subjects (independent
samples t-tests; left, p = 0.017; right, p = 0.001); values weren ± SD)
Controls
(Mean ± SD)
[B]
[A] vs [B]
p values
± 8.8
43)
47.4 ± 8.9
(n = 61)
0.56
39:22 0.38
± 5.2
43)
24.8 ± 3.7
(n = 61)
b 0.001*
± 19.3
43)
– –
± 4.9
43)
5.5 ± 3.5
(n = 61)
b 0.001*
4.0
43)
3.8 ± 2.5
(n = 61)
b 0.001*
± 2
40)
– –
± 10.3
36)
– –
± 10.6
36)
– –
± 21.4
30)
– –
8.3
43)
3.9 ± 4.4
(n = 61)
b0.001*
± 12.4
43)
3.9 ± 5.0
(n = 61)
0.001*
69.7 ± 73,557.7
43)
713,303.3 ± 77,941.7
(n = 61)
0.40
47.5 ± 56,252.4
43)
458,578.8 ± 63,000.5
(n = 61)
0.27
75.5 ± 167,583.0
43)
298,249.2 ± 175,544.6
(n = 61)
0.62
,092.6 ± 206,276.6
43)
1,470,131.3 ± 199,550.1
(n = 61)
0.82
.6 ± 666.0
.9 ± 461.6
43)
3909.1 ± 502.4
3929.3 ± 461.1
(n = 61)
0.041
0.043**
.8 ± 654.5
.2 ± 465.2
43)
3897.6 ± 487.8
3917.0 ± 472.3
(n = 61)
0.025
0.027**
7 ± 75.64
8 ± 84.52
19
870.00 ± 92.30
870.50 ± 84.48
n = 21
0.017
0.016##
5 ± 67.94
3 ± 91.68
19
889.12 ± 112.18
889.58 ± 91.65
n = 21
0.001
0.001##
Sleepiness Scale; PSQI, Pittsburgh Sleep Quality Index; SaO2, O2 saturation; BDI-II, Beck
cranial volume; *, equal variances not assumed; **, p value adjusted for age, gender, and
Fig. 1. Global putamen volumes of OSA and control subjects. Both left and right putamen
volumes were signiﬁcantly increased in recently-diagnosed, treatment naïve OSA over
control subjects, controlling for age, gender, and TIV (left, p = 0.043; right, p = 0.027).
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gender (ANCOVA; left, p = 0.016; right, p = 0.001).3.5. Relationships between global putamen volumes and BMI, sleep, O2
saturation, left and right putamenmd values, and neuropsychologic variables
Coefﬁcients of correlation and signiﬁcance levels among putamen
volumes, BMI, sleep, O2 saturation, left and right putamen MD values,
and neuropsychologic variables are tabulated in Table 2. Signiﬁcant neg-
ative correlations appeared between global putamen volumes, BMI
(left; r=−0.35 p= 0.022; right, r=−0.32, p= 0.036), and putamen
MD values (left; r=−0.48, p= 0.035; right, r =−0.46, p= 0.047) in
OSA subjects. However, no signiﬁcant correlations emerged between
putamen volumes and AHI, PSQI, or ESS scores. The BAI scores signiﬁ-
cantly correlated with putamen volumes (left; r = −0.39 p = 0.01;
right, r = −0.40, p = 0.008); however, BDI-II scores did not show
any correlations. The O2 desaturation nadir showed a signiﬁcant associ-
ation with left putamen volume (r =−0.34, p = 0.045); but, other O2
saturation variables did not show any relationships.3.6. Regional putamen volume changes
Multiple regions within the putamen showed increased and de-
creased ratios of radial distance of surface points from the medial
curve, indicating increased or decreased regional volume in OSA, com-
pared to control subjects. Regions with decreased volumes within the
putamen in OSA subjects included bilateral rostral (Fig. 2a, b, f, n, and
q), mid-dorsal (Fig. 2c, g, and h), medial-caudal (Fig. 2d, j, and p), and
mid-ventral sites (Fig. 2k, p), and increased volumes included the left
caudal-dorsal (Fig. 2e), right mid-dorsal (Fig. 2i), left mid-ventral
portions (Fig. 2l, m), and right caudal-ventral area (Fig. 2o).3.7. Putamen volume and linear regression analyses
Regression analyses ﬁndings are summarized in Table 3. Oxygen
saturation nadir (p= 0.045, B =−20.46) was an independent predic-
tor for left global putamen volume in OSA subjects. However, no
variable independently predicted right global putamen volume in
these subjects.4. Discussion
4.1. Overview
Newly-diagnosed, treatment-naïve OSA subjects show increased
global putamen volumes, but localized areas within the putamen
show both higher and lower volumes compared to control subjects.
The appearance of both increased and decreased volumes suggests
that we obtained a snapshot of progressive putamen tissue changes
early in the development of the chronic OSA condition, in which both
tissue swelling and loss occur, likely depending on the nature of the
composite structure and local perfusion. The putamen sites with altered
volume in OSA are associated with somatic and autonomic motor and
neuropsychologic regulatory roles, all of which are deﬁcient in the
condition (Bedard et al., 1991; Beebe et al., 2003; Berry et al., 1986).
4.2. OSA and brain injury
The putamen, togetherwith other basal ganglia and brain structures,
shows graymatter volume loss, gray matter and ﬁber injury, and meta-
bolic abnormalities in patients in chronic stages of the OSA syndrome
(Kamba et al., 1997; Macey et al., 2002; Morrell et al., 2003), rather
than the increased volume in the newly-diagnosed cases studied here.
Those prior studies in chronic OSA subjects, based on volumetric proce-
dures, showed reduced regional tissue volume changes, indicating
chronic tissue injury with late OSA diagnosis (Macey et al., 2002;
Morrell et al., 2003). However, in newly-diagnosed OSA subjects,
acute tissue changes are predominantly accompanied by axonal, glial,
and neuronal swelling, i.e., larger volumes, but show decreased mean
diffusivity values in the sameOSA subject pool, indicative of acute tissue
injury (Kumar et al., 2012). The increased overall structural volumes
found here should be viewed in this context of apparent injury fromdif-
fusion tensor imaging, but global increased volume from resultant
swelling; the progression of the syndrome will be accompanied by
later volume declines. The localized declines in volume may follow
different time courses for different brain structures; selected brain
areas, such as the mammillary bodies, show reduced volumes early in
the disease process (Kumar et al., 2008). Moreover, subareas within
the putamen may vary in vascularization and tissue composition with
different time courses of tissue loss.
4.3. Global and regional putamen volumes and OSA functional changes
Global putamen volumes were signiﬁcantly increased in OSA over
control subjects, despite sub-regions showing both increased and de-
creased volumes. The putamen contains dopaminergic neurons, sends
those projections to the substantia nigra and ventral tegmentum
(Gorbachevskaya, 1997; Schultz and Romo, 1987), and receives projec-
tions from the thalamus, insular cortices, and prefrontal cortex
(Avendano et al., 2006; Ferry et al., 2000), areas which are also injured
in OSA subjects (Kumar et al., 2012; Macey et al., 2002, 2008). Putamen
sub-regions are involved in various functions, including those heavily
inﬂuenced by dopamine released by midbrain projections (Inase et al.,
1997; Schultz, 1986).
Various putamen sites, including bilateral rostral, mid-dorsal,
medial-caudal, mid-ventral and ventral, and caudal-dorsal regions
showed either increased or decreased volume in OSA subjects; both
types of tissue changesmay be associatedwith altered function. The pu-
tamen primarily serves motor regulation functions, receiving projec-
tions from motor and somatosensory areas for that role (Kunzle,
1977). The rostral putamen receives projections from the prerubral
area of the substantia nigra through the lateral hypothalamus, internal
capsule and the head of the caudate nucleus (Usunoff et al., 1976).
Somatosensory and motor cortex areas representing the lower limbs,
ventromedial portions of facial regions, and upper limb regions project
to the dorsolateral putamen, and these projecting sites send ﬁbers in a
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388 R. Kumar et al. / NeuroImage: Clinical 4 (2014) 383–391rostro-caudal direction (Kunzle, 1975, 1977). Both premotor and sup-
plementary motor areas representing the face (Muakkassa and Strick,
1979), also send projections to the ventral medial putamen (Kunzle,
1978; Miyata and Sasaki, 1984). The ventrolateral globus pallidus pro-
jects to the ventrolateral thalamus,which represents oral and upper air-
way regions (DeVito and Anderson, 1982). Supplementary motor areas
and the caudolateral substantia nigra are involved in orofacial control
(Boussaoud and Joseph, 1985). Both the globus pallidus and substantia
nigra sites receive projections from rostroventral putamen (DeVito
et al., 1980). Since a principal concern in OSA is somatic motor regula-
tion of the oral airway, localized damage to subareas of the putamen
involved in such regulation is of great interest in the syndrome.
Multiple autonomic motor and neurobehavioral issues, including
altered memory, attention, psychomotor and executive function, and
emotional regulation are affected in OSA subjects (Bedard et al., 1991;
Beebe et al., 2003; Berry et al., 1986). The putamen contains dopaminer-
gic neurons, the neurotransmitter principally involved in mediating re-
ward. Injury to ventral putamen sub-regions served bydopamine-based
neurotransmitters would have signiﬁcant effects on affective behaviors
dependent on reward (Seeman et al., 2006); those behaviors are heavily
affected in OSA (Asghari et al., 2012). A primary characteristic of OSA is
impaired autonomic nervous system regulation, reﬂected especially in
excessive sympathetic activity and impaired timing to autonomic chal-
lenges (Harper et al., 2003; Henderson et al., 2002; Somers et al., 1995).
Injury to both the insular cortices and dorsal putamen likely contributes
to that deﬁcit, since both regions serve autonomic roles; the putamen
receives projections from the insular cortices (Saper, 1982), and both
structures show overall injury and functional deﬁcits during autonomic
and respiratory challenges (Henderson et al., 2004; Kumar et al., 2012;
Macey et al., 2006). Since a close relationship exists between transient
elevation in blood pressure with both diaphragmatic (Trelease et al.,
1985) and upper airway action (Marks and Harper, 1987), and upper
airwaymuscle suppression ismore sensitive to blood pressure elevation
than the diaphragm, distorted regulation of dynamic sympathetic
patterns has the potential to contribute to the “motor neglect” of
upper airway muscles found in OSA.
4.4. Tissue volume changes: processes
Several mechanisms may underlie the global and regional putamen
tissue changes. OSA subjects are intermittently exposed to hypoxia from
the repeated, successive cessations of airﬂow during sleep, which is
followed by rapid re-oxygenation at apnea termination. Moreover, ex-
aggerated blood pressure swings occur over the course of each apneic
event, with substantial changes in perfusion accompanying the vascular
alterations (Yan et al., 2009). Hypoxic and ischemic conditions induce
energy pump failure, altering sodium and potassium ion distribution,
and affecting intracellular and extracellular water, resulting in neuronal
and axonal swelling (Hossmann, 1971; Lowry et al., 1964;Mintorovitch
et al., 1994; Oehmichen et al., 2001). The axonal and neuronal swelling
increases volumes of affected brain structures. However, chronic stages
of hypoxia/ischemia would be accompanied by a reduction in axons,
neurons, and glia, leaving a net loss of tissue volume over control values.
Since OSA subjects showed higher global putamen volumes, relative to
control subjects, we believe that the tissue changes are representative
of acute changes. These changes likely contribute to manifestations of
characteristics in OSA.
Both increased and decreased localized volume changes appeared in
OSA subjects within the putamen over controls, suggesting that the
changes result from both early and long-standing tissue alterations in
these newly-diagnosed, treatment-naïve subjects, or that portions of
the putamen may be more vulnerable to hypoxic or perfusion changes
through the nature of tissue composition or extent of vascularization.
Overall, the predominant changes appear to be in acute stages, since
global putamen volumes were found to be signiﬁcantly increased in
OSA over controls. These ﬁndings suggest that a series of changes occurs
Fig. 2.Areas of regional putamen volume increase and decrease in OSA compared to control subjects, with areas shown from a dorsal perspective (Left), and a ventral perspective (Right).
The color coding represents ratios of radial distance of each surface point from control reference values, with warm colors (orange to red) indicating volume losses and cool colors (blue to
purple) representing volume increases; those corresponding sites are labeledwith letters (a–q). Bilateral siteswith increased putamen volume in the OSA group includedmid and caudal-
ventral portions, based on OSA to control group ratios, and decreased volumes emerged in bilateral rostral and mid-dorsal regions, extending to ventral areas (a–q).
389R. Kumar et al. / NeuroImage: Clinical 4 (2014) 383–391within tissue before axonal and neuronal loss, with early, acute stages of
pathology associatedwith increased tissue volume,while chronic stages
of pathology are accompanied by decreased volumes. Tissue changes
in both acute and chronic stages of pathology likely contribute to func-
tional deﬁcits served by subareas within the structure.
It is possible, although speculative, that theOSA conditionmay result
fromputamen tissue changes, i.e., that the failure in upper airway action
results from initial putamen dysfunction from injury which may prog-
ress, cumulating with the exaggerated autonomic and other manifesta-
tions found in OSA. Initial putamen injury, perhaps by carbonmonoxide
poisoning, accidental hypoxic exposure, or reaction to toxic substances
acting on the multiple neurotransmitters in the structure, has the po-
tential to interferewith normal putamen functioning, disrupting normal
regulation of the upper airway. This initial dysfunctionmay escalate to a
condition that self-perpetuates or worsens, with all of the autonomic
and somatomotor outcomes reported for OSA. Determination of the
feasibility of such an outcome would require basic studies of insults to
the putamen in an animal model that results in interference with
upper airway muscle action paralleling the coordination loss found in
human OSA.Table 3
Comparison ofmultivariate p values and B values of AHI, BMI, sleep, neuropsychologic, left
and right putamenMD values, and O2 saturation variables for the linear regression analy-
ses in OSA subjects.
Side Covariates Multivariate p values B
Left putamen volume AHI 0.573 –
BMI 0.175 –
ESS 0.892 –
PSQI 0.950 –
BDI–II 0.897 –
BAI 0.567 –
O2 saturation nadir 0.045 –20.46
Right putamen volume AHI – –
BMI – –
ESS – –
PSQI – –
BDI-II – –
BAI – –
O2 saturation nadir – –
AHI, apnea–hypopnea-index; BMI, bodymass index; ESS, Epworth Sleepiness Scale; PSQI,
Pittsburgh Sleep Quality Index; BDI-II, Beck Depression Inventory II; BAI, Beck Anxiety
Inventory; MD, mean diffusivity.4.5. Limitations
One limitation of this study is the absence of data on the pre-
diagnosis duration of OSA subjects. However, we are reasonably conﬁ-
dent that the predominant brain tissue changes in the OSA subjects
are acute in nature. MRI-based mean diffusivity (MD) procedures,
which measure water diffusion within tissue, and are inﬂuenced by
the presence of tissue barriers and extracellular/extra-axonal ﬂuid,
show reduced MD values in acute disease stages of ischemic/hypoxic
pathology, but show increased values in chronic stages of such patholo-
gy (Ahlhelm et al., 2002; Chan et al., 2009; Hossmann et al., 1994;
Loubinoux et al., 1997; Matsumoto et al., 1995; Shereen et al., 2011;
Warach et al., 1996). Since these same OSA subjects showed reduced
MD values across various brain sites (Kumar et al., 2012), we believe
that the predominant tissue pathology in this sample derives from
damage in acute stages.
5. Conclusions
Newly-diagnosedOSA subjectswithout treatment showsigniﬁcantly
increased global putamen volumes over control subjects, with sub-
regionswithin the structure showing both increased and decreased vol-
umes. Regional sites with decreased volumes emerged in rostral, mid-
dorsal, medial-caudal, and mid-ventral areas, and increased volumes
appeared in caudal-dorsal, mid-dorsal, mid-ventral, and caudal-ventral
portions. These areas contribute to regulation of neuropsychologic,
autonomic motor, and somatomotor functions deﬁcient in OSA, and es-
pecially to oral motor functioning, a special concern in the syndrome
due to airway collapse in obstructive apnea. The pathological processes
contributing to tissue changes may include intermittent hypoxia and
impaired perfusion, both of which can affect glial tissue necessary for
neuronal support; such tissue is extremely sensitive to hypoxia and
ischemia. The ﬁnding of regional increased and decreased volume
variation indicates that ﬁnal volume loss earlier found in long-term
OSA occurs with a progression of changes in the tissue.
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